This Month's Top Stories from Endocrinology Network

April 11, 2019

Are blood sugar levels moving targets? Should pregnant women be screened for thyroid cancer? And, will there soon be treatment to stave off those salt and sugar cravings? Learn more about these and other developments from endocrinology research in this news recap.

Are blood sugar levels moving targets? Should pregnant women be screened for thyroid cancer? And, will there soon be treatment to stave off those salt and sugar cravings?Â Learn more about these and other developments from endocrinology research in this news recap.

Love Drug Weakens Neural Response to Food: The hormone oxytocin shows promise as a possible new treatment for obesity, according to research presented on Monday at ENDO 2019. (©Minerva Studio, AdobeStock)

A1c Test Fails to Catch Most Diabetes Cases: The hemoglobin A1C test underestimates the prevalence of diabetes in patients, shows new research presented at ENDO 2019. (Hemoglobin A1c test, ©Sherry Young, AdobeStock)

Tumor Growth Rate Doesn’t Predict Malignancy in AUS-A Thyroid Nodules: The American Thyroid Association guidelines recommend repeat fine-needle aspiration, molecular testing or diagnostic surgical resection if thyroid nodule size increases significantly, but a new study shows there is little evidence that significant tumor growth is a predictor of malignancy, especially in architectural atypia of undetermined significance (AUS-A) cases. (©Kateryna_Kon, AdobeStock)

Is less than 7 percent a reasonable A1C goal? At ENDO 2019, two experts offered differing perspectives on optimal A1C targets. Blood sugar levels, one doctor said, should fall under 7 percent. Another physician argued for 7-8 percent. Learn more about the debate in this article. (©PittaWut, AdobeStock)

Early Diabetic Ketoacidosis may Impact Brain Development: In very young children with type 1 diabetes, even a single episode of moderate/severe diabetic ketoacidosis (DKA) can potentially have long-term effects on cognitive abilities and brain growth, a study shows. (©Milenie, AdobeStock.com)

Should Pregnant Women be Screened for Thyroid Disease? Primary care providers, endocrinologists and obstetricians have been challenged with the question of whether to screen all pregnant women for thyroid disease. The debate springs primarily from unknown clinical implications of subclinical thyroid disease during pregnancy. This issue was addressed at ENDO 2019. (©SydaProductionsShutterStock.com)

What drives your burnout? What drives your burnout? Better yet, how do you prevent yourself from getting burned out? Dr. Chao raises this important issue in this month's physician column. (©MonikaWisniewska_AdobeStock)

Disease Pathways for Diabetic Retinopathy Vary Between Patients: Diabetic retinopathy is the leading cause of blindness among working adults in the United States, but disease pathways may vary between patients, new research shows. (Diabetes Retinopathy, ©AdobeStock_Koolsabuy)

A Gene Discovery for the Deadly Fulminant Type 1 Diabetes: Fulminant type 1 diabetes is rare, sudden and often deadly. New research published in the journal Diabetes describes a key discovery that could lead to new treatments for this condition. (©DavidCarillet, AdobeStock)